The mutagenic effects of 7,12-dimethylbenz[a]anthacene, 3-methylcholanthrene and benzo[a]pyrene to the developing Syrian hamster fetus measured by an in vivo/in vitro mutation assay

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 554, Issue 1-2, 2004, Pages 111-120

  Donovan, Paul J ^a   Smith, George T ^a   Nardone, Roland ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CATHOLIC UNIVERSITY OF AMERICA   (United States)

Author keywords

3 Methylcholanthrene; 7,12 Dimethylbenz a anthracene; Benzo a pyrene; Diphtheria toxin; Embryo; Fetus; In vivo; Mutagenicity test; Mutation; Somatic cells; Transplacental

Indexed keywords

3 METHYLCHOLANTHRENE; 7,12 DIMETHYLBENZ[A]ANTHRACENE; BENZO[A]PYRENE; DIPHTHERIA TOXIN; ETHYLNITROSOUREA; POLYCYCLIC AROMATIC HYDROCARBON;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; EXPOSURE; FEMALE; FETUS; FETUS CELL; FETUS DEVELOPMENT; FIRST TRIMESTER PREGNANCY; GENETIC ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR CLONING; MUTAGENICITY; MUTATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SYRIAN HAMSTER; TIME;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BENZO(A)PYRENE; CRICETINAE; FETUS; MESOCRICETUS; METHYLCHOLANTHRENE; MUTAGENS; MUTATION;

CRICETINAE; MESOCRICETUS AURATUS;

EID: 4344622144     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2004.04.003     Document Type: Article

References (66)

1. Bulay O.M., Wattenberg L.W. Carcinogenic effects of polycyclic hydrocarbon carcinogen administration to mice during pregnancy on the progeny. J. Natl. Cancer Inst. 46:1971;397-402
2. Bulay O.M., Wattenberg L.W. Carcinogenic effects of subcutaneous administration of benzo(a)pyrene during pregnancy on the progeny. Proc. Soc. Exp. Biol. Med. 135:1970;84-86
3. Tomatis L., Turusov V., Guibbert D., Duperray B., Malaveille C., Pacheco H. Transplacental carcinogenic effect of 3-methylcholanthrene in mice and its quantitation in fetal tissues. J. Natl. Cancer Inst. 47:1971;645-651
4. Napalkov N.P., Alexandrov V.A. Neurotropic effect of 7,12-dimethylbenz(a) anthracene in transplacental carcinogenesis. J. Natl. Cancer Inst. 52:1974;1365-1366
5. J.M. Rice, S.R. Joshi, R.E. Shenefelt, M.L. Wenk, Transplacental carcinogenic activity of 7,12-dimethylbenz[a]anthracene, Carcinogenesis - a Comprehensive Study 3 (Polynucl. Aromat. Hydrocarbons) (1978) 413-422.
6. Napalkov N., Likhachev A., Anisimov V., Loktionov A., Zabezhinski M., Ovsyannikov A., Wahrendorf J., Becher H., Tomatis L. Promotion of skin tumours by TPA in the progeny of mice exposed pre-natally to DMBA. Carcinogenesis. 8:1987;381-385
7. Rao A.R. 7,12-Dimethylbenz[a]anthracene-induced perinatal carcinogenesis and its modulation by butylated hydroxyanisole in mice. IARC Sci. Publ. 96:1989;63-74
8. Alexandrov V.A. Embryotoxic and teratogenic effects of chemical carcinogens. IARC Sci. Publ. 4:1973;112-126
9. Goerttler K., Loehrke H., Schweizer J., Hesse B. Two-stage skin carcinogenesis by systemic initiation of pregnant mice with 7,12-dimethylbenz(a) anthracene during gestation days 6-20 and postnatal promotion of the F 1-generation with the phorbol ester 12-tetradecanoylphorbol-13-acetate. J. Cancer Res. Clin. Oncol. 98:1980;267-275
10. Goerttler K., Loehrke H., Hesse B., Milz A., Schweizer J. Diaplacental initiation of NMRI mice with 7,12-dimethylbenz[a]anthracene during gestation days 6-20 and postnatal treatment of the F1-generation with the phorbol ester 12-O-tetradecanoylphorbol-13-acetate: tumor incidence in organs other than the skin. Carcinogenesis. 2:1981;1087-1094
11. Morris E.P., Burns F.J., Albert R.E. Transplacental skin tumor initiation of Ha/ICR mice at different fetal ages. Cancer Res. 43:1983;4271-4274
12. Anderson L.M., Diwan B.A., Fear N.T., Roman E. Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models. Environ. Health Perspect. 108(Suppl. 3):2000;573-594
13. Loktionov A., Popovich I., Zabezhinski M., Martel N., Yamasaki H., Tomatis L. Transplacental and transgeneration carcinogenic effect of 7,12-dimethylbenz[a]anthracene: relationship with ras oncogene activation. Carcinogenesis. 13:1992;19-24
14. Loktionov A., Hollstein M., Martel N., Galendo D., Cabral J.R.P., Tomatis L., Yamasaki H. Tissue-specific activating mutations of Ha- and Ki-ras oncogenes in skin, lung, and liver tumors induced in mice following transplacental exposure to DMBA. Mol. Carcinog. 3:1990;134-140
15. Anderson L.M., Jones A.B., Miller M.S., Chauhan D.P. Metabolism of transplacental carcinogens. IARC Sci. Publ. 96:1989;155-188
16. Anderson L.M., Ruskie S., Carter J., Pittinger S., Kovatch R.M., Riggs C.W. Fetal mouse susceptibility to transplacental carcinogenesis: differential influence of Ah receptor phenotype on effects of 3-methylcholanthrene, 12-dimethylbenz[a]anthracene, and benzo[a]pyrene. Pharmacogenetics. 5:1995;364-372
17. Winn L.M., Wells P.G. Evidence for embryonic prostaglandin H synthase-catalyzed bioactivation and reactive oxygen species-mediated oxidation of cellular macromolecules in phenytoin and benzo[a]pyrene teratogenesis. Free Radic. Biol. Med. 22:1997;607-621
18. McCann J., Choi E., Yamasaki E., Ames B.N. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc. Natl. Acad. Sci. U.S.A. 72:1975;5135-5139
19. Bartsch H., Malaveille C., Camus A.-M., Martel-Planche G., Brun G., Hautefeuille A., Sabadie N., Barbin A., Kuroki T., Drevon C., Piccoli C., Montesano R. Validation and comparative studies on 180 chemicals with S. typhimurium strains and V79 Chinese hamster cells in the presence of various metabolizing systems. Mutat. Res. 76:1980;1-50
20. De Flora S., Zanacchi P., Camoirano A., Bennicelli C., Badolati G.S. Genotoxic activity and potency of 135 compounds in the Ames reversion test and in a bacterial DNA-repair test. Mutat. Res. 133:1984;161-198
21. Bradley M.O., Bhuyan B., Francis M.C., Langenbach R., Peterson A., Huberman E. Mutagenesis by chemical agents in V79 Chinese hamster cells: a review and analysis of the literature. A report of the Gene-Tox Program. Mutat. Res. 87:1981;81-142
22. Rocchi P., Arfellini G., Capucci A., Grilli M.P., Prodi G. Effect of vitamin A palmitate on mutagenesis induced by polycyclic aromatic hydrocarbons in human cells. Carcinogenesis. 4:1983;245-247
23. Mavournin K.H., Blakey D.H., Cimino M.C., Salamone M.F., Heddle J.A. The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res. 239:1990;29-80
24. Heddle J.A., Hite M., Kirkhart B., Mavournin K., MacGregor J.T., Newell G.W., Salamone M.F. The induction of micronuclei as a measure of genotoxicity. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res. 123:1983;61-118
25. Donovan P.J., Smith G.T., Riggs C.W. Hamster and rat fetal cells have low spontaneous mutation frequencies and rates. Mutat. Res. 478:2001;51-63
26. Donovan P.J., Smith G.T. Cell sensitivity to transplacental mutagenesis by N-ethyl-N-nitrosourea is greatest during early gestation in the Syrian hamster. Mutat. Res. 427:1999;47-58
27. Hill H.Z., Miller C.L. Plating efficiency of mouse embryo cells as a function of gestational age. Experientia. 32:1976;1054-1055
28. Glover T.W., Chang C.-C., Trosko J.E., Li S.S.L. Ultraviolet light induction of diphtheria toxin-resistant mutants in normal and xeroderma pigmentosum human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 76:1979;3982-3986
29. W.J. Dixon, F.J. Massey Jr., Introduction to Statistical Analysis, McGraw-Hill, New York, 1951.
30. Russell L.B., Montgomery C.S. Ethylnitrosourea is highly potent in the mammalian spot test. Environ. Mutagen. 2:1980;284
31. Wang M.-Y., Lu L.-J.W. Differential effect of gestation stage on benzo(a)pyrene-induced micronucleus formation and/or covalent DNA modifications in mice. Cancer Res. 50:1990;2146-2151
32. Müller L. Micronucleus induction in mouse and rat fetuses treated transplacentally during histogenesis with mitomycin C and 7,12-dimethylbenz(a) anthracene. Teratog. Carcinog. Mutagen. 8:1988;303-313
33. Müller L. Stage-related induction of chromosomal aberrations and SCE in mouse embryos treated transplacentally during organogenesis with MMC and DMBA. Teratog. Carcinog. Mutagen. 8:1988;95-105
34. Iball J. The relative potency of carcinogenic compounds. Amer. J. Cancer. 35:1939;188-190
35. M.H.L. Snow, Restorative growth in mammalian embryos, in: H. Kalter (Ed.), Issues and Reviews in Teratology, Plenum Press, New York, 1983, pp. 251-284.
36. Stoner G.D., Schut H.A.J., Daniel F.B., Dixit R. A comparison of covalent DNA binding of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in respiratory tissues from human, rat and mouse. Cancer Lett. 30:1986;231-241
37. Melendez-Colon V.J., Luch A., Seidel A., Baird W.M. Cancer initiation by polycyclic aromatic hydrocarbons results from formation of stable DNA adducts rather than apurinic sites. Carcinogenesis. 20:1999;1885-1891
38. Doerjer G., Diessner H., Bücheler J., Kleihues P. Reaction of 7,12-dimethylbenz(a)anthracene with DNA of fetal and maternal rat tissues in vivo. Int. J. Cancer. 22:1978;288-291
39. Lu L.-J.W., Harvey R.G., Lee H., Baxter J.R., Anderson L.M. Age-, tissue-, and Ah genotype-dependent differences in the binding of 3-methylcholanthrene and its metabolite(s) to mouse DNA. Cancer Res. 50:1990;4239-4247
40. Borman S.M., Christian P.J., Sipes I.G., Hoyer P.B. Ovotoxicity in female Fischer rats and B6 mice induced by low-dose exposure to three polycyclic aromatic hydrocarbons: comparison through calculation of an ovotoxic index. Toxicol. Appl. Pharmacol. 167:2000;191-198
41. Davila D.R., Romero D.L., Burchiel S.W. Human T cells are highly sensitive to suppression of mitogenesis by polycyclic aromatic hydrocarbons and this effect is differentially reversed by α-naphthoflavone. Toxicol. Appl. Pharmacol. 139:1996;333-341
42. Thurmond L.M., Lauer L.D., House R.V., Cook J.C., Dean J.H. Immunosuppression following exposure to 7,12-dimethylbenz[a]anthracene (DMBA) in Ah-responsive and Ah-nonresponsive mice. Toxicol. Appl. Pharmacol. 91:1987;450-460
43. Matsuoka A., Ozaki M., Takeshita K., Sakamoto H., Glatt H.-R., Hayashi M., Sofuni T. Aneuploidy induction by benzo[a]pyrene and polyploidy induction by 7,12-dimethylbenz[a]anthracene in Chinese hamster cell lines V79-MZ and V79. Mutagenesis. 12:1997;365-372
44. Khan Q.A., Vousden K.H., Dipple A. Lack of p53-mediated G1 arrest in response to an environmental carcinogen. Oncology. 57:1999;258-264
45. Dipple A., Khan Q.A., Page J.E., Pontén I., Szeliga J. DNA reactions, mutagenic action and stealth properties of polycyclic aromatic hydrocarbon carcinogens (review). Int. J. Oncol. 14:1999;103-111
46. Juchau M.R., DiGiovanni J., Namkung M.J., Jones A.H. A comparison of the capacity of fetal and adult liver, lung, and brain to convert polycyclic aromatic hydrocarbons to mutagenic and cytotoxic metabolites in mice and rats. Toxicol. Appl. Pharmacol. 49:1979;171-178
47. Alexander D.L., Eltom S.E., Jefcoate C.R. Ah receptor regulation of CYP1B1 expression in primary mouse embryo-derived cells. Cancer Res. 57:1997;4498-4506
48. Buters J.T.M., Sakai S., Richter T., Pineau T., Alexander D.L., Savas U., Doehmer J., Ward J.M., Jefcoate C.R., Gonzalez F.J. Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas. Proc. Natl. Acad. Sci. U.S.A. 96:1999;1977-1982
49. Shimada T., Inoue K., Suzuki Y., Kawai T., Azuma E., Nakajima T., Shindo M., Kurose K., Sugie A., Yamagishi Y., Fujii-Kuriyama Y., Hashimoto M. Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice. Carcinogenesis. 23:2002;1199-1207
50. Shimada T., Oda Y., Gillam E.M.J., Guengerich F.P., Inoue K. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009. Drug Metab. Dispos. 29:2001;1176-1182
51. Shen Z., Liu J., Wells R.L., Elkind M.M. cDNA cloning, sequence analysis, and induction by aryl hydrocarbons of a murine cytochrome P450 gene, Cyp1b1. DNA Cell Biol. 13:1994;763-769
52. 32P -postlabeling and use of knockout mice for Ah receptor-independent mechanisms of metabolic activation in vivo Int. J. Cancer. 103:2003;5-11
53. Bentley P., Schmassmann H., Sims P., Oesch F. Epoxides derived from various polycyclic hydrocarbons as substrates of homogeneous and microsome-bound epoxide hydratase. Eur. J. Biochem. 69:1976;97-103
54. Miyata M., Kudo G., Lee Y.-H., Yang T.J., Gelboin H.V., Fernandez-Salguero P., Kimura S., Gonzalez F.J. Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a]anthracene. J. Biol. Chem. 274:1999;23963-23968
55. Lu L.-J., Anderson L.M., Jones A.B., Moskal T.J., Salazar J.J., Hokanson J.A., Rice J.M. Persistence, gestation stage-dependent formation and interrelationship of benzo[a]pyrene-induced DNA adducts in mothers, placentae and fetuses of Erythrocebus patas monkeys. Carcinogenesis. 14:1993;1805-1813
56. Pershagen G. Childhood cancer and malignancies other than lung cancer related to passive smoking. Mutat. Res. 222:1989;129-135
57. Gold E.B., Leviton A., Lopez R., Gilles F.H., Hedley-Whyte E.T., Kolonel L.N., Lyon J.L., Swanson G.M., Weiss N.S., West D., Aschenbrener C., Austin D.F. Parental smoking and risk of childhood brain tumors. Am. J. Epidemiol. 137:1993;620-628
58. Shu X.-O., Ross J.A., Pendergrass T.W., Reaman G.H., Lampkin B., Robison L.L. Parental alcohol consumption, cigarette smoking, and risk of infant leukemia: a childrens cancer group study. J. Natl. Cancer Inst. 88:1996;24-31
59. Yang Q., Olshan A.F., Bondy M.L., Shah N.R., Pollock B.H., Seeger R.C., Look A.T., Cohn S.L. Parental smoking and alcohol comsumption and risk of neuroblastoma. Cancer Epidemiol. Biomarkers Prev. 9:2000;967-972
60. Boffetta P., Trédaniel J., Greco A. Risk of childhood cancer and adult lung cancer after childhood exposure to passive smoke: a meta-analysis. Environ. Health Perspect. 108:2000;73-82
61. Schüz J., Kaatsch P., Kaletsch U., Meinert R., Michaelis J. Association of childhood cancer with factors related to pregnancy and birth. Int. J. Epidemiol. 28:1999;631-639
62. Brondum J., Shu X.-O., Steinbuch M., Severson R.K., Potter J.D., Robison L.L. Parental cigarette smoking and the risk of acute leukemia in children. Cancer. 85:1999;1380-1388
63. Norman M.A., Holly E.A., Ahn D.K., Preston-Martin S., Mueller B.A., Bracci P.M. Prenatal exposure to tobacco smoke and childhood brain tumors: results from the United States West Coast childhood brain tumor study. Cancer Epidemiol. Biomarkers Prev. 5:1996;127-133
64. Klebanoff M.A., Clemens J.D., Read J.S. Maternal smoking during pregnancy and childhood cancer. Am. J. Epidemiol. 144:1996;1028-1033
65. Sorahan T., Prior P., Lancashire R.J., Faux S.P., Hultén M.A., Peck I.M., Stewart A.M. Childhood cancer and parental use of tobacco: deaths from 1971 to 1976. Br. J. Cancer. 76:1997;1525-1531
66. Stjernfeldt M., Berglund K., Lindsten J., Ludvigsson J. Maternal smoking and irradiation during pregnancy as risk factors for child leukemia. Cancer Detect. Prev. 16:1992;129-135